Rocket Pharmaceuticals

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RCKT and other ETFs, options, and stocks.

About RCKT

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms.

CEO

Gaurav D. Shah

CEOGaurav D. Shah

Employees

151

Employees151

Headquarters

Cranbury, New Jersey

HeadquartersCranbury, New Jersey

Founded

1999

Founded1999

Employees

151

Employees151

RCKT Key Statistics

Market cap

1.06B

Market cap1.06B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

1.30M

Average volume1.30M

High today

$16.02

High today$16.02

Low today

$14.35

Low today$14.35

Open price

$14.50

Open price$14.50

Volume

2.73M

Volume2.73M

52 Week high

$36.87

52 Week high$36.87

52 Week low

$7.57

52 Week low$7.57

Analyst ratings

100%

of 13 ratings

Buy

100%

Hold

Sell

RCKT Earnings

-$0.83

-$0.55

-$0.28

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 3, After Hours

ActualExpected Nov 3, After Hours